From January 1, 2023 to May 23, 2023, the company has repurchased 202,445 shares, representing 0.6% for KRW 2,286 million. With this, the company has completed the repurchase of 1,840,483 shares, representing 5.22% for KRW 29,899.64 million under the buyback announced on March 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,640 KRW | -0.60% |
|
-0.30% | -25.98% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
1st Jan change | Capi. | |
---|---|---|
-25.98% | 163M | |
-11.78% | 11.24B | |
-13.76% | 7.29B | |
+29.50% | 5.57B | |
-19.19% | 3.68B | |
+7.62% | 2.58B | |
-65.24% | 2.33B | |
-10.48% | 2.23B | |
+27.80% | 2.21B | |
-19.12% | 1.57B |
- Stock Market
- Equities
- A950130 Stock
- News Access Bio, Inc.
- Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.